Loading…
Abemaciclib dose escalation to maintain intensity (ADE-MI)
Gadi, VK, Danciu, Oana Cristina, Hoskins, Kent, Ibraheem, Abiola Falilat, Owens, Jovonne, Chen, Zhengjia
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data
GEBBIA, VITTORIO, MARTORANA, FEDERICA, SANÒ, MARIA VITA, VALERIO, MARIA ROSARIA, GIOTTA, FRANCESCO, SPADA, MASSIMILIANO, PIAZZA, DARIO, CARUSO, MICHELE, VIGNERI, PAOLO
Published in Anticancer research (01.03.2023)
Published in Anticancer research (01.03.2023)
Get full text
Journal Article
Loading…
Loading…
Multicenter phase II study of abemaciclib and ramucirumab in metastatic esophageal/gastroesophageal junction carcinoma
Kelly, Ronan Joseph, Lam, Vincent K., Paulson, Scott, Settele, Natalie, Sido, Oghenevovwero, Anagnostou, Valsamo, Raj, Moses S., Zaidi, Ali Hussainy
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Abstract P1-10-14: Abemaciclib tablet formulation is bioequivalent to capsules
Turner, PK, Chappell, JC, Aburub, A, Ng, WT, Zhang, W, Royalty, J, Kulanthaivel, P
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Loading…
Loading…
Phase 3 ENABLAR-2 study to evaluate enobosarm and abemaciclib combination compared to estrogen-blocking agent for the second-line treatment of AR+, ER+, HER2- metastatic breast cancer in patients who previously received palbociclib and estrogen-blocking agent combination therapy
Lim, Elgene, Brufsky, Adam, Rugo, Hope S., Vogel, Charles L., O'Shaughnessy, Joyce, Getzenberg, Robert H., Barnette, K. Gary, Rodriguez, Domingo, Bird, Gary, Steiner, Mitchell S., Linden, Hannah M.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics
Chigutsa, Emmanuel, Kambhampati, Siva Rama Prasad, Karen Sykes, Amanda, Posada, Maria M., Walt, Jan‐Stefan, Turner, P. Kellie
Published in CPT: pharmacometrics and systems pharmacology (01.09.2020)
Published in CPT: pharmacometrics and systems pharmacology (01.09.2020)
Get full text
Journal Article
Loading…
Abstract PO3-18-05: Pharmacokinetics (PK) of lasofoxifene (LAS) monotherapy and combined with abemaciclib (Abema)
Damodaran, Senthil, Plourde, Paul V., Jenkins, Simon, Mayer, Phil, Portman, David J, Goetz, Matthew
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Loading…
Phase II study of the combination of abemaciclib and pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Uboha, Nataliya Volodymyrivna, Eickhoff, Jens C., Chandrasekharan, Chandrikha, Jalal, Shadia Ibrahim, Benson, Al Bowen, Deming, Dustin A., Lindemann, Stephen, Hochster, Howard S.
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Loading…
Abstract P1-02-24: Leveraging bulk and single-cell RNA sequencing to identify features predicting response and survival to abemaciclib in six mouse models of breast cancer
Agrawal, Yash, Mott, Kevin, Yilmaz-Swenson, Tulay, Perou, Charles M.
Published in Clinical cancer research (13.06.2025)
Published in Clinical cancer research (13.06.2025)
Get full text
Journal Article
Loading…
Abstract CT153: Pharmacokinetic drug interactions between abemaciclib and CYP3A inducers and inhibitors
Kulanthaivel, Palaniappan, Mahadevan, Daruka, Turner, P. Kellie, Royalty, Jane, Ng, Wee Teck, Yi, Ping, Rehmel, Jessica, Cassidy, Kenneth, Chappell, Jill
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Loading…
Loading…
RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS
Bagley, Stephen, Nasrallah, MacLean, O’Rourke, Donald, Hussain, Jasmin, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, Desai, Arati
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
Loading…
Abstract P1-12-08: Biomarker analysis of hepatotoxicity in a Phase II study of nivolumab, abemaciclib and endocrine therapy in patients with HR-positive, HER2-negative breast cancer: WJOG11418BTR NEWFLAME_TR
Tsurutani, Junji, Masuda, Jun, Masuda, Norikazu, Tanabe, Yuko, Iwasa, Tsutomu, Takahashi, Masato, Futamura, Manabu, Matsumoto, Koji, Aogi, Kenjiro, Iwata, Hiroji, Hosonaga, Mari, Mukohara, Toru, Yoshimura, Kiyoshi, Imamura, Chiyo K., Miura, Sakiko, Yamochi, Toshiko, Yoshimura, Kenichi, Takano, Toshimi, Kawabata, Hidetaka
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Loading…
Abstract PO4-27-06: Design of Active Phase 3 ENABLAR-2 Study Evaluating Enobosarm +/- Abemaciclib in Patients with AR+ER+HER2- 2nd-Line Metastatic Breast Cancer Following Tumor Progression on an Estrogen Blocking Agent Plus Palbociclib or Ribociclib
Rinn, Kristine, Linden, Hannah, Schwartzberg, Lee, Barnette, Gary, Rodriguez, Domingo, Shalev, Itay, Steiner, Mitchell, Brufsky, Adam, O'Shaughnessy, Joyce
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Loading…
Abstract P1-12-08: Biomarker analysis of hepatotoxicity in a Phase II study of nivolumab, abemaciclib and endocrine therapy in patients with HR-positive, HER2-negative breast cancer: WJOG11418BTR NEWFLAME_TR
Junji Tsurutani, Jun Masuda, Norikazu Masuda, Yuko Tanabe, Tsutomu Iwasa, Masato Takahashi, Manabu Futamura, Koji Matsumoto, Kenjiro Aogi, Hiroji Iwata, Mari Hosonaga, Toru Mukohara, Kiyoshi Yoshimura, Chiyo K. Imamura, Sakiko Miura, Toshiko Yamochi, Kenichi Yoshimura, Toshimi Takano, Hidetaka Kawabata
Published in Cancer Research (01.03.2023)
Published in Cancer Research (01.03.2023)
Get full text
Journal Article
Loading…
Loading…